STATE STREET CORP - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is and the CUSIP is 67011XAB9. A total of 33 filers reported holding NOVOCURE LTD in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$12,796,292
+24.9%
14,928,000
+25.2%
0.00%0.0%
Q2 2023$10,248,437
+2.6%
11,928,000
+3.0%
0.00%0.0%
Q1 2023$9,991,490
-55.8%
11,578,000
-54.6%
0.00%0.0%
Q4 2022$22,616,078
+86.1%
25,490,000
+85.4%
0.00%0.0%
Q3 2022$12,152,000
+10.2%
13,750,000
+8.7%
0.00%0.0%
Q2 2022$11,026,000
-11.9%
12,650,000
-8.0%
0.00%0.0%
Q1 2022$12,519,000
-22.9%
13,750,000
-21.9%
0.00%0.0%
Q4 2021$16,233,00017,600,0000.00%
Other shareholders
NOVOCURE LTD shareholders Q2 2023
NameSharesValueWeighting ↓
STEELHEAD PARTNERS LLC 67,736,000$60,446,9294.40%
BRAIDWELL LP 131,834,000$117,582,7453.94%
DeepCurrents Investment Group LLC 38,391,000$34,368,1761.34%
SHENKMAN CAPITAL MANAGEMENT INC 16,861,000$14,946,8630.93%
Context Capital Management, LLC 12,489$11,1390.82%
WOLVERINE ASSET MANAGEMENT LLC 76,557,000$68,630,3670.71%
ABSOLUTE INVESTMENT ADVISERS, LLC 3,500,000$3,113,2500.47%
Aequim Alternative Investments LP 18,000,000$16,054,2000.44%
Ionic Capital Management LLC 2,000,000$1,781,5550.42%
Verition Fund Management LLC 27,771,000$24,768,9550.39%
View complete list of NOVOCURE LTD shareholders